BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31868336)

  • 1. Immunocytochemical characteristics of thyrocytes in radioiodine refractory metastases of papillary thyroid cancer.
    Zelinskaya A
    Exp Oncol; 2019 Dec; 41(4):342-345. PubMed ID: 31868336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry.
    Shield PW; Crouch SJ; Papadimos DJ; Walsh MD
    Cytopathology; 2018 Jun; 29(3):227-232. PubMed ID: 29508480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation.
    Thomas D; Liakos V; Vassiliou E; Hatzimarkou F; Tsatsoulis A; Kaldrimides P
    J Endocrinol Invest; 2007 Mar; 30(3):173-80. PubMed ID: 17505148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation.
    Mourão GF; Rosario PW; Calsolari MR
    Endocr Relat Cancer; 2016 Jan; 23(1):47-52. PubMed ID: 26503963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low postoperative nonstimulated thyroglobulin as a criterion for the indication of low radioiodine activity in patients with papillary thyroid cancer of intermediate risk 'with higher risk features'.
    Rosario PW; Mourão GF; Calsolari MR
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):453-8. PubMed ID: 26801644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Lymph Node Fine-Needle Aspiration and Needle-Wash Thyroglobulin Reflex Test for Papillary Thyroid Carcinoma.
    Zhang X; Howell JM; Huang Y
    Endocr Pathol; 2018 Dec; 29(4):346-350. PubMed ID: 30203321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential changes in serum thyroid peroxidase following radioiodine therapy of patients with differentiated thyroid carcinoma.
    Ozata M; Bayhan H; Bingöl N; Dündar S; Beyhan Z; Corakci A; Gundogan MA
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3634-8. PubMed ID: 8530612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes for the detection of metastatic papillary thyroid carcinoma.
    Li QK; Nugent SL; Straseski J; Cooper D; Riedel S; Askin FB; Sokoll LJ
    Cancer Cytopathol; 2013 Aug; 121(8):440-8. PubMed ID: 23495036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.
    Li J; Liang J; Zhao T; Lin Y
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1034-9. PubMed ID: 26780618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
    Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
    J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low postoperative nonstimulated serum thyroglobulin level excludes the presence of persistent disease in low-risk papillary thyroid cancer patients: implication for radioiodine indication.
    Rosario PW; Mourão GF; Siman TL; Calsolari MR
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):957-61. PubMed ID: 25393656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Molecular Profiles of Primary
    Gomes-Lima CJ; Shobab L; Wu D; Ylli D; Bikas A; McCoy M; Feldman R; Lee W; Rao SN; Jensen K; Vasko V; Castro LC; Jonklaas J; Wartofsky L; Burman KD
    Front Endocrinol (Lausanne); 2021; 12():623182. PubMed ID: 33716974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
    Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
    Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine Uptake and Thyroglobulin-Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-Label, Controlled Trial.
    Jin Y; Ruan M; Cheng L; Fu H; Liu M; Sheng S; Chen L
    Thyroid; 2019 Jan; 29(1):101-110. PubMed ID: 30560716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular and gene/miRNA expression profiles of radioiodine resistant papillary thyroid cancer.
    Colombo C; Minna E; Gargiuli C; Muzza M; Dugo M; De Cecco L; Pogliaghi G; Tosi D; Bulfamante G; Greco A; Fugazzola L; Borrello MG
    J Exp Clin Cancer Res; 2020 Nov; 39(1):245. PubMed ID: 33198784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.